11 Ovulation, ovulation induction and ovarian carcinoma

Atlas, 1982, Massive hyperstimulation and borderline carcinoma of the ovary. A possible association, Acta Obstetrica et Gynecologica Scandinavica, 61, 261, 10.3109/00016348209156568 Bamford, 1982, Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy. Case report, British Journal of Obstetrics and Gynaecology, 89, 962, 10.1111/j.1471-0528.1982.tb05067.x Bartocci, 1986, Regulation of colony-stimulating factor 1 during pregnancy, Journal of Experimental Medicine, 164, 956, 10.1084/jem.164.3.956 Ben-Hur, 1986, Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Case report, Acta Obstetrica et Gynecologica Scandinavica, 65, 813, 10.3109/00016348609161511 Biskind, 1944, Development of tumors in the rat ovary after transplantation into the spleen, 55, 176 Bjorkholm, 1980, Granulosa-cell and theca-cell tumors. The clinical picture and long-term outcome for the Radiumhemmet series, Acta Obstetrica et Gynecologica Scandinavica, 59, 361, 10.3109/00016348009154094 Booth, 1989, Risk factors for ovarian cancer: a case-control study, British Journal of Cancer, 60, 592, 10.1038/bjc.1989.320 Brinton, 1989, Cancer risk after evaluation for infertility, American Journal of Epidemiology, 129, 712, 10.1093/oxfordjournals.aje.a115186 Cancer and Steroid Hormone Study of the Centers for Disease Control, 1987, The reduction in risk of ovarian cancer associated with oral contraceptive use, New England Journal of Medicine, 316, 650, 10.1056/NEJM198703123161102 Carter, 1987, Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report, Journal of In Vitro Fertilization and Embryo Transfer, 4, 126, 10.1007/BF01555453 Casagrande, 1979, Incessant ovulation and ovarian cancer, Lancet, ii, 170, 10.1016/S0140-6736(79)91435-1 Cramer, 1985, Letter to the editor, Journal of the National Cancer Institute, 75, 179 Cramer, 1983, Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis, Journal of the National Cancer Institute, 71, 717 Cramer, 1982, Factors affecting the association of oral contraceptives and ovarian cancer, New England Journal of Medicine, 307, 1047, 10.1056/NEJM198210213071703 Cruickshank, 1990, Aetiological importance of ovulation in epithelial ovarian cancer: a population based study, British Medical Journal, 301, 524, 10.1136/bmj.301.6751.524 1984, 289 Evans, 1980, Clinicopathological review of 118 granulosa and 82 theca cell tumors, Obstetics and Gynecology, 55, 231 Fathalla, 1971, Incessant ovulation—a factor in ovarian neoplasia?, Lancet, ii, 163, 10.1016/S0140-6736(71)92335-X Goldberg, 1992, Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation—is there a link?, American Journal of Obstetrics and Gynecology, 166, 853, 10.1016/0002-9378(92)91348-E Graves, 1985, Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators, American Journal of Obstetrics and Gynecology, 153, 877, 10.1016/0002-9378(85)90693-3 Gwinn, 1990, Pregnancy, breast feeding and oral contraceptives and the risk of epithelial cancer, Journal of Clinical Epidemiology, 43, 559, 10.1016/0895-4356(90)90160-Q Hartge, 1989, A case-control study of epithelial ovarian cancer, American Journal of Obstetrics and Gynecology, 161, 10, 10.1016/0002-9378(89)90221-4 Hatch, 1991, Responsiveness of patients with advanced ovarian carcinoma to tamoxifen, Cancer, 68, 269, 10.1002/1097-0142(19910715)68:2<269::AID-CNCR2820680209>3.0.CO;2-O Heintz, 1985, Epidemiology and etiology of ovarian cancer: a review, Obstetrics and Gynecology, 66, 127 Henderson, 1988, Estrogens as a cause of human cancer: The Richard and Hilda Rosenthal Foundation Award Lecture, Cancer Research, 48, 246 Hildreth, 1981, An epidemiologic study of epithelial carcinoma of the ovary, American Journal of Epidemiology, 114, 398, 10.1093/oxfordjournals.aje.a113207 Hoover, 1977, Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer, Lancet, ii, 533, 10.1016/S0140-6736(77)90667-5 Jacobs, 1990, Potential screening test for ovarian cancer, 200 Jacobs, 1988, Multimodal approach to screening for ovarian cancer, Lancet, i, 268, 10.1016/S0140-6736(88)90351-0 Johannes, 1992, Side of origin of epithelial ovarian cancer, British Medical Journal, 304, 27, 10.1136/bmj.304.6818.27 Lais, 1988, Prevalence of ovarian cancer found at the time of infertility microsurgery, Fertility and Sterility, 49, 551, 10.1016/S0015-0282(16)59792-1 Langdon, 1990, Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines, British Journal of Cancer, 62, 213, 10.1038/bjc.1990.263 La Vecchia, 1986, Oral contraceptives and cancers of the breast and of the female genital tract. Interim reports of a case-control study, British Journal of Cancer, 54, 311, 10.1038/bjc.1986.178 Leake, 1990, The prognostic value of steroid receptors, growth factors and growth factor receptors in ovarian cancer, 69 Lee, 1990, Frequent loss of heterozygosity on chromosomes 6q, 11 and 17 in human ovarian carcinomas, Cancer Research, 50, 2724 Lowry, 1991, Incessant ovulation and ovarian cancer, Lancet, 337, 1544, 10.1016/0140-6736(91)93233-Y Lynch, 1978, Familial association of breast/ovarian cancer, Cancer, 41, 1543, 10.1002/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y Malik, 1991, Epithelial ovarian cancer: a cytokine propelled disease?, British Journal of Cancer, 64, 617, 10.1038/bjc.1991.372 McGowan, 1979, The women at risk for developing ovarian cancer, Gynecologic Oncology, 7, 325, 10.1016/0090-8258(79)90111-2 Merkus, 1990, Het ovariumhyperstimulatiesyndroom, Nederlands Tijdschrift voor Geneeskunde, 134, 944 Mohle, 1985, Gonadotrophins and ovarian cancer risk, Journal of the National Cancer Institute, 75, 178 Nasca, 1984, An epidemiologic casecontrol study of ovarian cancer and reproductive factors, American Journal of Epidemiology, 119, 705, 10.1093/oxfordjournals.aje.a113791 Nash, 1989, Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro, Obstetrics and Gynecology, 73, 1009 Newhouse, 1977, A case-control study of carcinoma of the ovary, British Journal of Preventive and Social Medicine, 31, 148 Nijman, 1992, Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases, European Journal of Cancer, 12, 1971, 10.1016/0959-8049(92)90240-3 Ohel, 1983, Granulosa cell tumors in Israel. A study of 172 cases, Gynecologic Oncology, 15, 278, 10.1016/0090-8258(83)90083-5 Posthelwaite, 1990, Stimulation of fibroblast chemotaxis by human recombinant tumour necrosis factor α (TMF-α) and a synthetic TNF-α31-68 peptide, Journal of Experimental Medicine, 172, 1749, 10.1084/jem.172.6.1749 Potashink, 1987, Frequency, sequence, and side of ovulation in women menstruating normally, British Medical Journal, 294, 219, 10.1136/bmj.294.6566.219 Rajaniemi, 1981, LH (hCG) receptor in benign and malignant tumors of human ovary, Acta Obstetrica et Gynecologica Scandinavica Supplement, 101, 83, 10.3109/00016348109157818 Risch, 1983, Events of reproductive life and the incidence of epithelial ovarian cancer, American Journal of Epidemiology, 117, 128, 10.1093/oxfordjournals.aje.a113523 Ron, 1987, Cancer incidence in a cohort of infertile women, American Journal of Epidemiology, 125, 780, 10.1093/oxfordjournals.aje.a114595 Rosenberg, 1982, Epithelial ovarian cancer and combination oral contraceptives, Journal of the American Medical Association, 247, 3210, 10.1001/jama.1982.03320480026020 Russell, 1990, Allele loss from chromosome 17 in ovarian cancer, Oncogene, 5, 1581 Shu, 1989, Population-based case-control study of ovarian cancer in Shanghai, Cancer Research, 49, 3670 Simon, 1983, Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones, Journal of the National Cancer Institute, 70, 839 Snijders, 1990, Is immunohistochemical analysis of oestrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay?, Journal of Pathology, 161, 129, 10.1002/path.1711610207 Soutter, 1987, Steroid hormone receptors in gynecological cancers, 15, 175 Stanford, 1991, Oral contraceptives and neoplasia of the ovary, Contraception, 43, 543, 10.1016/0010-7824(91)90003-X Tzonou, 1984, The epidemiology of ovarian cancer in Greece: a case-control study, European Journal of Cancer and Clinical Oncology, 20, 1045, 10.1016/0277-5379(84)90107-X UKCCCR, 1989, Report of a workshop to the UKCCCR Subcommittee for Coordination of Research into Gynaecological Cancers, 461 Weiss, 1977, Incidence of the histologic types of ovarian cancer: the US Third National Cancer Survey, 1969–1971, Gynecologic Oncology, 5, 161, 10.1016/0090-8258(77)90020-8 Weiss, 1981, Incidence of ovarian cancer in relation to the use of oral contraceptives, International Journal of Cancer, 28, 669, 10.1002/ijc.2910280602 Weiss, 1982, Noncontraceptive estrogen use and the occurrence of ovarian cancer, Journal of the National Cancer Institute, 68, 95 Whittemore, 1989, Epithelial ovarian cancer and the ability to conceive, Cancer Research, 49, 4047 1989, Epithelial ovarian cancer and combined oral contraceptives, International Journal of Epidemiology, 18, 538, 10.1093/ije/18.3.538 Wildrick, 1989, Molecular genetic studies of colon cancer, Hematology/Oncology Clinics of North America, 3, 1, 10.1016/S0889-8588(18)30564-1 Willett, 1981, Oral contraceptives and risk of ovarian cancer, Cancer, 48, 1684, 10.1002/1097-0142(19811001)48:7<1684::AID-CNCR2820480735>3.0.CO;2-A 1991 Wu, 1988, Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use, American Journal of Epidemiology, 128, 1216, 10.1093/oxfordjournals.aje.a115076